Mirati Therapeutics
MRTX
#3050
Rank
โ‚ฌ3.92 B
Marketcap
55,91ย โ‚ฌ
Share price
0.00%
Change (1 day)
54.56%
Change (1 year)

Mirati Therapeutics (MRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2023 : โ‚ฌ0.17 Billion

According to Mirati Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ0.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Mirati Therapeutics - Total liabilities on balance sheet (from 2005 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ0.19 B13.52%
2021-12-31โ‚ฌ0.16 B80.53%
2020-12-31โ‚ฌ93.77 M110.49%
2019-12-31โ‚ฌ44.54 M89.61%
2018-12-31โ‚ฌ23.49 M101.97%
2017-12-31โ‚ฌ11.63 M-19.15%
2016-12-31โ‚ฌ14.38 M59.87%
2015-12-31โ‚ฌ9 M102.07%
2014-12-31โ‚ฌ4.45 M-84.09%
2013-12-31โ‚ฌ27.98 M587.5%
2012-12-31โ‚ฌ4.07 M40.57%
2011-12-31โ‚ฌ2.89 M-43.76%
2010-12-31โ‚ฌ5.14 M-18.68%
2009-12-31โ‚ฌ6.33 M-18.32%
2008-12-31โ‚ฌ7.75 M-59.81%
2007-12-31โ‚ฌ19.28 M3.61%
2006-12-31โ‚ฌ18.61 M269.51%
2005-12-31โ‚ฌ5.03 M17.56%
2004-12-31โ‚ฌ4.28 M-33.38%
2003-12-31โ‚ฌ6.43 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ2.57 B 1,378.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.99 M-98.28% Bahamas